Programmed cell death ligand 1 (PD-L1) is an example of such an immune checkpoint, and is upregulated in a broad range of cancers, including lung [12], renal cell [13–15], pancreatic [16–18], ovarian cancer [19] and hematologic malignancies [20, 21]. This evidence concerns the gene CD274 and cancer.